Endogenous viral elements constitute a complementary source of antigens for personalized cancer vaccines
C. Garde, M. A. Pavlidis, P. Garces, E. J. Lange, S. H. Ramarathinam, M. Sokac, K. Pandey, P. Faridi, J. Ahrenfeldt, S. Chung, S. Friis, D. Kleine-Kohlbrecher, N. J. Birkbak, J. V. Kringelum, B. Rono, , T. Trolle
This paper identifies endogenous viral elements as a new source of antigens for personalized cancer vaccines and introduces a computational pipeline to predict and test their therapeutic potential.
bioRxiv · Mar 23, 2023Cancer Biology